Qiagen NV
Qiagen NV (QGEN) Option Chain
As of September 23, 2026, Qiagen NV is trading at $43.71, a +0.05% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 46.5%. IV Rank is 52%.
Read more
Tracking the QGEN option chain helps you see every strike and expiry on Qiagen NV in one view, so you can quickly identify the contracts that fit your thesis and your risk. Qiagen NV's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of QGEN options activity at a glance. Use our scanner to monitor the QGEN option chain in real time and filter for the QGEN options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For QGEN stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the QGEN option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where QGEN stock options are being actively traded and where they are not.
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories.
It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Qiagen NV's full chain across every expiry, highlights the most liquid strikes, and lets you screen QGEN options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of QGEN stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryDiagnostics & Research
- SectorHealthcare
- IV percentile46.03% Neutral
- Market cap (M$)9,008
- 52 weeks high-24.40%
- 52 weeks low34.37%
- Analyst recommendationBuy
2.27 - Target price$45.95
5.12% above the current stock price - Dividend—
- Payout ratio12.88%
- Earnings date2026-11-03
- P/E22.20
- Future P/E16.74
- EPS (ttm)1.97
- EPS growth next 5 years6.25%
As of September 23, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 3.59 | 0 | 0 | 0.34 | 8.71 | 7.50 | 10.60 | 35.00 | -19.22 | — | 2.20 | 0.00 | 2.20 | 0 | 1 | 96.41 |
| 25.66 | 5 | 0 | 0.94 | 3.71 | 3.20 | 6.10 | 40.00 | -7.69 | 0.65 | 1.10 | 0.00 | 0.88 | 1,515 | 549 | 74.34 |
| 63.97 | 1,509 | 84 | 1.30 | 0.00 | 1.05 | 1.55 | 45.00 | +3.85 | 2.20 | 3.80 | 1.29 | 1.71 | 0 | 43 | 36.03 |
| 89.66 | 78 | 98 | 0.60 | 0.00 | — | 0.60 | 50.00 | +15.39 | 5.30 | 7.90 | 6.29 | 0.31 | 0 | 0 | 10.34 |
| 98.13 | 1,000 | 0 | 0.45 | 0.00 | — | 0.45 | 55.00 | +26.93 | 10.30 | 12.90 | 11.29 | 0.31 | 0 | 0 | 1.87 |
As of September 23, 2026
Scan the full option chain in one place
Browse the full QGEN option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→